Improvement in quality of life of patients with myofascial pain treated with either conservative therapy only or conservative therapy with early self-physiotherapy

A randomized controlled trial investigating the impact of conservative therapy alone versus conservative therapy with early self-physiotherapy on quality of life in patients with myofascial pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12874881

Enrollment

Registered

2025-03-19

Start date

2021-08-01

Completion date

Unknown

Last updated

2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improving quality of life of patients of temporomandibular joint disorder Musculoskeletal Diseases

Interventions

Sixty-two patients diagnosed with myofascial pain were randomly allocated to either of two treatment groups using Lottery method: Group A received conservative therapy alone, while Group B underwent c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with myofascial pain (DC-TMD Axis 1 Group 1 only) 2. Both genders (male and female) 3. Age 20 - 40 years 4. Dentate

Exclusion criteria

Exclusion criteria: 1. Patients with systemic health disorders including CVS, CNS, respiratory, endocrine, systemic musculoskeletal etc. 2. Known Psychiatric or psychological conditions 3. Those not willing to participate in research 4. Those already under treatment 5. Missing data for any variable 6. Deep bite 7. Neuropathic pain 8. A history of TMJ surgery 9. Condylar fractures

Design outcomes

Primary

Measure	Time frame
Validated QOL index was used to assess quality of life before and after 4 weeks of therapy	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Pakistan

Contacts

Public ContactIqra Saleem

doctoriqrasaleem@gmail.com+92 3218825239

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026